Cargando…
Extracellular serglycin upregulates the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the MAPK/β-catenin axis
Serglycin is a proteoglycan that was first found to be secreted by hematopoietic cells. As an extracellular matrix (ECM) component, serglycin promotes nasopharyngeal carcinoma (NPC) metastasis and serves as an independent, unfavorable NPC prognostic indicator. The detailed mechanism underlying the r...
Autores principales: | Chu, Qiaoqiao, Huang, Hongbing, Huang, Tiejun, Cao, Li, Peng, Lixia, Shi, Simei, Zheng, Lisheng, Xu, Liang, Zhang, Shijun, Huang, Jialing, Li, Xinjian, Qian, Chaonan, Huang, Bijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260886/ https://www.ncbi.nlm.nih.gov/pubmed/27809309 http://dx.doi.org/10.1038/cddis.2016.287 |
Ejemplares similares
-
The autoregulatory serglycin/CD44 axis drives stemness‐like phenotypes in TNBC in a β‐catenin‐dependent manner
por: Cao, Li, et al.
Publicado: (2021) -
Significance of serglycin and its binding partners in autocrine promotion of metastasis in esophageal cancer
por: Zhu, Yun, et al.
Publicado: (2021) -
Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner
por: Guo, J-Y, et al.
Publicado: (2017) -
Serglycin in human cancers
por: Li, Xin-Jian, et al.
Publicado: (2011) -
Cathepsin L promotes chemresistance to neuroblastoma by modulating serglycin
por: Du, Xiaohuan, et al.
Publicado: (2022)